Literature DB >> 30862608

Machine learning identifies an immunological pattern associated with multiple juvenile idiopathic arthritis subtypes.

Erika Van Nieuwenhove1,2,3, Vasiliki Lagou2,3,4, Lien Van Eyck1,2,3, James Dooley2,3, Ulrich Bodenhofer5,6,7, Carlos Roca2,3, Marijne Vandebergh4, An Goris4, Stéphanie Humblet-Baron2,3, Carine Wouters1,3, Adrian Liston8,3,9.   

Abstract

OBJECTIVES: Juvenile idiopathic arthritis (JIA) is the most common class of childhood rheumatic diseases, with distinct disease subsets that may have diverging pathophysiological origins. Both adaptive and innate immune processes have been proposed as primary drivers, which may account for the observed clinical heterogeneity, but few high-depth studies have been performed.
METHODS: Here we profiled the adaptive immune system of 85 patients with JIA and 43 age-matched controls with indepth flow cytometry and machine learning approaches.
RESULTS: Immune profiling identified immunological changes in patients with JIA. This immune signature was shared across a broad spectrum of childhood inflammatory diseases. The immune signature was identified in clinically distinct subsets of JIA, but was accentuated in patients with systemic JIA and those patients with active disease. Despite the extensive overlap in the immunological spectrum exhibited by healthy children and patients with JIA, machine learning analysis of the data set proved capable of discriminating patients with JIA from healthy controls with ~90% accuracy.
CONCLUSIONS: These results pave the way for large-scale immune phenotyping longitudinal studies of JIA. The ability to discriminate between patients with JIA and healthy individuals provides proof of principle for the use of machine learning to identify immune signatures that are predictive to treatment response group. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  B cells; T cells; autoimmune diseases; juvenile idiopathic arthritis

Mesh:

Year:  2019        PMID: 30862608     DOI: 10.1136/annrheumdis-2018-214354

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  12 in total

Review 1.  Machine Learning in Rheumatic Diseases.

Authors:  Mengdi Jiang; Yueting Li; Chendan Jiang; Lidan Zhao; Xuan Zhang; Peter E Lipsky
Journal:  Clin Rev Allergy Immunol       Date:  2021-02       Impact factor: 8.667

2.  Signatures of GVHD and relapse after posttransplant cyclophosphamide revealed by immune profiling and machine learning.

Authors:  Shannon R McCurdy; Vedran Radojcic; Hua-Ling Tsai; Ante Vulic; Elizabeth Thompson; Sanja Ivcevic; Christopher G Kanakry; Jonathan D Powell; Brian Lohman; Djamilatou Adom; Sophie Paczesny; Kenneth R Cooke; Richard J Jones; Ravi Varadhan; Heather J Symons; Leo Luznik
Journal:  Blood       Date:  2022-01-27       Impact factor: 22.113

Review 3.  Machine Learning Techniques for Personalised Medicine Approaches in Immune-Mediated Chronic Inflammatory Diseases: Applications and Challenges.

Authors:  Junjie Peng; Elizabeth C Jury; Pierre Dönnes; Coziana Ciurtin
Journal:  Front Pharmacol       Date:  2021-09-30       Impact factor: 5.810

Review 4.  Interfering with interferons: targeting the JAK-STAT pathway in complications of systemic juvenile idiopathic arthritis (SJIA).

Authors:  Emely L Verweyen; Grant S Schulert
Journal:  Rheumatology (Oxford)       Date:  2022-03-02       Impact factor: 7.046

5.  Early Prediction of Clinical Response to Etanercept Treatment in Juvenile Idiopathic Arthritis Using Machine Learning.

Authors:  Xiaolan Mo; Xiujuan Chen; Chifong Ieong; Song Zhang; Huiyi Li; Jiali Li; Guohao Lin; Guangchao Sun; Fan He; Yanling He; Ying Xie; Ping Zeng; Yilu Chen; Huiying Liang; Huasong Zeng
Journal:  Front Pharmacol       Date:  2020-07-31       Impact factor: 5.810

6.  Early and Accurate Prediction of Clinical Response to Methotrexate Treatment in Juvenile Idiopathic Arthritis Using Machine Learning.

Authors:  Xiaolan Mo; Xiujuan Chen; Hongwei Li; Jiali Li; Fangling Zeng; Yilu Chen; Fan He; Song Zhang; Huixian Li; Liyan Pan; Ping Zeng; Ying Xie; Huiyi Li; Min Huang; Yanling He; Huiying Liang; Huasong Zeng
Journal:  Front Pharmacol       Date:  2019-10-07       Impact factor: 5.810

7.  Coupling of Co-expression Network Analysis and Machine Learning Validation Unearthed Potential Key Genes Involved in Rheumatoid Arthritis.

Authors:  Jianwei Xiao; Rongsheng Wang; Xu Cai; Zhizhong Ye
Journal:  Front Genet       Date:  2021-02-11       Impact factor: 4.599

8.  Application of systems biology-based in silico tools to optimize treatment strategy identification in Still's disease.

Authors:  Cristina Segú-Vergés; Mireia Coma; Christoph Kessel; Serge Smeets; Dirk Foell; Anna Aldea
Journal:  Arthritis Res Ther       Date:  2021-04-23       Impact factor: 5.156

9.  The promise of machine learning to inform the management of juvenile idiopathic arthritis.

Authors:  Simon W M Eng; Rae S M Yeung; Quaid Morris
Journal:  Expert Rev Clin Immunol       Date:  2021-01-26       Impact factor: 4.473

10.  Disease-associated and patient-specific immune cell signatures in juvenile-onset systemic lupus erythematosus: patient stratification using a machine-learning approach.

Authors:  George A Robinson; Junjie Peng; Pierre Dönnes; Leda Coelewij; Meena Naja; Anna Radziszewska; Chris Wincup; Hannah Peckham; David A Isenberg; Yiannis Ioannou; Ines Pineda-Torra; Coziana Ciurtin; Elizabeth C Jury
Journal:  Lancet Rheumatol       Date:  2020-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.